المؤلفون: Karamasis GV; Cardiology Department, National and Kapodistrian University of Athens Medical School, Attikon University Hospital, Athens, Greece., Polyzogopoulou E; Emergency Medicine Department, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Varlamos C; Cardiology Department, National and Kapodistrian University of Athens Medical School, Attikon University Hospital, Athens, Greece., Frantzeskaki F; Department of Critical Care Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Dragona VM; Cardiology Department, National and Kapodistrian University of Athens Medical School, Attikon University Hospital, Athens, Greece., Boultadakis A; Emergency Medicine Department, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Bistola V; Cardiology Department, National and Kapodistrian University of Athens Medical School, Attikon University Hospital, Athens, Greece., Fountoulaki K; Cardiology Department, National and Kapodistrian University of Athens Medical School, Attikon University Hospital, Athens, Greece., Pappas C; Cardiology Department, National and Kapodistrian University of Athens Medical School, Attikon University Hospital, Athens, Greece., Kolokathis F; Cardiology Department, National and Kapodistrian University of Athens Medical School, Attikon University Hospital, Athens, Greece., Pavlopoulos D; Department of Cardiac Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Toumpoulis IK; Department of Cardiac Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Kollias VD; Department of Cardiac Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Farmakis D; Cardiology Department, National and Kapodistrian University of Athens Medical School, Attikon University Hospital, Athens, Greece., Rallidis LS; Cardiology Department, National and Kapodistrian University of Athens Medical School, Attikon University Hospital, Athens, Greece., Angouras DC; Department of Cardiac Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Tsangaris I; Department of Critical Care Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Parissis JT; Emergency Medicine Department, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Filippatos G; Cardiology Department, National and Kapodistrian University of Athens Medical School, Attikon University Hospital, Athens, Greece. Electronic address: gfilippatos@gmail.com.

المصدر: Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese [Hellenic J Cardiol] 2024 Jul 02. Date of Electronic Publication: 2024 Jul 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101257381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2241-5955 (Electronic) Linking ISSN: 11099666 NLM ISO Abbreviation: Hellenic J Cardiol Subsets: MEDLINE

المؤلفون: Alexopoulos D; 2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece., Dragona VM; Red Cross General Hospital, Athens, Greece., Varlamos C; 2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece., Ktenas D; Department of Cardiology, Patras University Hospital, Patras, Greece., Lianos I; 2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece., Patsilinakos S; Cardiology Department, Konstantopoulio General Hospital, Athens, Greece., Sionis D; Sismanoglion General Hospital, Athens, Greece., Zarifis I; General Hospital 'G. Papanikolaou', Thessaloniki, Greece., Bampali T; Ioannina University Hospital, Ioannina, Greece., Poulimenos L; Department of Cardiology 'Asklepeion' General Hospital Voula, Attica, Greece., Skalidis E; Department of Cardiology, Heraklion University Hospital, Crete, Greece., Pissimisis E; Tzanion Hospital, Piraeus, Greece., Trikas A; Elpis General Hospital, Athens, Greece., Tsiafoutis I; Red Cross General Hospital, Athens, Greece., Kafkas N; KAT General Hospital, Athens, Greece., Olympios C; Thriasio General Hospital, Elefsina, Greece., Tziakas D; Cardiology Department and Cardiac Cathetherization Lab, University Hospital of Alexandroupolis, Alexandroupolis, Greece., Ziakas A; 1st Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Voudris V; Cardiology Department, Onassis Cardiac Surgery Center, Athens, Greece., Kanakakis I; Alexandra General Hospital, Athens, Greece; and., Tsioufis C; First Cardiology Clinic, Medical School, Hippokration Hospital Athens, National and Kapodistrian University of Athens, Athens Greece., Davlouros P; Department of Cardiology, Patras University Hospital, Patras, Greece., Benetou DR; 2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.

المصدر: Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2023 Feb 01; Vol. 81 (2), pp. 141-149. Date of Electronic Publication: 2023 Feb 01.

نوع المنشور: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7902492 Publication Model: Electronic Cited Medium: Internet ISSN: 1533-4023 (Electronic) Linking ISSN: 01602446 NLM ISO Abbreviation: J Cardiovasc Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Atrial Fibrillation*/drug therapy , Percutaneous Coronary Intervention*/adverse effects, Humans ; Fibrinolytic Agents/adverse effects ; Greece ; Anticoagulants/adverse effects ; Hemorrhage/chemically induced ; Registries ; Vitamin K ; Platelet Aggregation Inhibitors/adverse effects

المؤلفون: Lianos I; 2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Rimini 1, Chaidari, 12462, Athens, Greece., Varlamos C; 2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Rimini 1, Chaidari, 12462, Athens, Greece., Benetou DR; 2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Rimini 1, Chaidari, 12462, Athens, Greece., Mantis C; Department of Cardiology, Konstantopoulion Hospital, Athens, Greece., Kintis K; Department of Cardiology, Konstantopoulion Hospital, Athens, Greece., Dragona VM; 3rd Department of Internal Medicine, Red Cross Hospital, Athens, Greece., Kanakakis I; Department of Clinical Therapeutics, 'Alexandra' University Hospital, Athens, Greece., Sionis D; Department of Cardiology, Sismanoglion Hospital, Athens, Greece., Patsilinakos S; Department of Cardiology, Konstantopoulion Hospital, Athens, Greece., Alexopoulos D; 2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Rimini 1, Chaidari, 12462, Athens, Greece. dalex@med.uoa.gr.

المصدر: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2023 Jan; Vol. 55 (1), pp. 42-50. Date of Electronic Publication: 2022 Nov 12.

نوع المنشور: Observational Study; Multicenter Study; Journal Article

بيانات الدورية: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9502018 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-742X (Electronic) Linking ISSN: 09295305 NLM ISO Abbreviation: J Thromb Thrombolysis Subsets: MEDLINE

مواضيع طبية MeSH: Atrial Fibrillation*/therapy , Percutaneous Coronary Intervention*/adverse effects, Humans ; Clopidogrel/therapeutic use ; Ticagrelor/therapeutic use ; Platelet Aggregation Inhibitors/adverse effects ; Fibrinolytic Agents/therapeutic use ; Anticoagulants/adverse effects ; Treatment Outcome

المؤلفون: Alexopoulos D; 1 2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece., Lianos I; 1 2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece., Vlachakis P; 1 2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece., Sfantou D; 1 2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece., Dragona VM; 1 2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece., Varlamos C; 1 2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.

المصدر: Journal of cardiovascular pharmacology and therapeutics [J Cardiovasc Pharmacol Ther] 2019 Jul; Vol. 24 (4), pp. 304-314. Date of Electronic Publication: 2019 Feb 05.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 9602617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1940-4034 (Electronic) Linking ISSN: 10742484 NLM ISO Abbreviation: J Cardiovasc Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Percutaneous Coronary Intervention*/adverse effects, Acute Coronary Syndrome/*therapy , Platelet Aggregation Inhibitors/*administration & dosage , Purinergic P2Y Receptor Antagonists/*administration & dosage, Acute Coronary Syndrome/diagnosis ; Administration, Oral ; Animals ; Clinical Decision-Making ; Coronary Thrombosis/etiology ; Coronary Thrombosis/prevention & control ; Drug Administration Schedule ; Drug Substitution ; Hemorrhage/chemically induced ; Humans ; Platelet Aggregation Inhibitors/adverse effects ; Purinergic P2Y Receptor Antagonists/adverse effects ; Risk Factors ; Treatment Outcome

المؤلفون: Xanthopoulou I; Cardiology Department, Patras University Hospital, Patras, Greece. jxanthop@yahoo.gr., Dragona VM; 3rd Department of Internal Medicine, Red Cross Hospital, Athens, Greece., Davlouros P; Cardiology Department, Patras University Hospital, Patras, Greece., Tsioufis C; 1st Department of Cardiology, Ippokration Hospital, National and Capodistrian University of Athens Medical School, Athens, Greece., Iliodromitis E; 2nd Department of Cardiology, Attikon University Hospital, National and Capodistrian University of Athens Medical School, Athens, Greece., Alexopoulos D; 2nd Department of Cardiology, Attikon University Hospital, National and Capodistrian University of Athens Medical School, Athens, Greece.

مؤلفون مشاركون: GRAPE-AF Investigators

المصدر: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2018 Apr; Vol. 32 (2), pp. 191-196.

نوع المنشور: Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE

مواضيع طبية MeSH: Percutaneous Coronary Intervention*/adverse effects, Anticoagulants/*administration & dosage , Atrial Fibrillation/*drug therapy , Blood Coagulation/*drug effects , Coronary Artery Disease/*therapy , Coronary Thrombosis/*prevention & control , Fibrinolytic Agents/*administration & dosage , Platelet Aggregation Inhibitors/*administration & dosage, Anticoagulants/adverse effects ; Atrial Fibrillation/blood ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/epidemiology ; Coronary Artery Disease/blood ; Coronary Artery Disease/diagnosis ; Coronary Artery Disease/epidemiology ; Coronary Thrombosis/blood ; Coronary Thrombosis/diagnosis ; Coronary Thrombosis/epidemiology ; Fibrinolytic Agents/adverse effects ; Greece/epidemiology ; Hemorrhage/chemically induced ; Humans ; Platelet Aggregation Inhibitors/adverse effects ; Prospective Studies ; Registries ; Research Design ; Risk Factors ; Time Factors ; Treatment Outcome